SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Metropolis Healthcare trades in green on the bourses

12 Apr 2021 Evaluate

Metropolis Healthcare is currently trading at Rs. 2528.75, up by 45.55 points or 1.83% from its previous closing of Rs. 2483.20 on the BSE.

The scrip opened at Rs. 2535.00 and has touched a high and low of Rs. 2605.00 and Rs. 2504.70 respectively. So far 11046 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2532.70 on 09-Apr-2021 and a 52 week low of Rs. 1150.00 on 14-May-2020.

Last one week high and low of the scrip stood at Rs. 2532.70 and Rs. 2130.00 respectively. The current market cap of the company is Rs. 13062.65 crore.

The promoters holding in the company stood at 50.39%, while Institutions and Non-Institutions held 41.83% and 7.78% respectively.

Metropolis Healthcare has achieved a revenue growth of 40% Year on Year (YoY) in Q4FY21 as compared to Q4FY20. Non-Covid Business revenue increased by 21% YoY in Q4FY21 as compared to Q4FY20. Inspite of conducting higher Covid Tests on QoQ basis, Covid Business revenue (RT-PCR Tests) stood at 14% of total revenue in Q4FY21 as compared to 19% in Q3FY21 due to reduction in Test prices by Government agencies.

The Company recorded highest ever monthly revenue in March 2021 on the back of strong growth in Non-covid business coupled with an uptick in covid business.

Metropolis Healthcare offers a comprehensive range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.

Metropolis Health. Share Price

550.30 44.65 (8.83%)
08-May-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×